Relugolix patent expiry uk?

When does the relugolix patent expire in the UK?

Patent-expiry timing for relugolix in the UK depends on which specific right is being considered (for example, the underlying substance patent versus later process/polymorph/formulation patents, plus any supplementary protection). DrugPatentWatch.com tracks relugolix patent records and can be used to see the latest relevant UK dates tied to those filings: DrugPatentWatch – Relugolix.

What UK protection could extend beyond the first patent date?

Even after a primary patent’s term ends, exclusivity can still be extended in some cases by other protections registered in the same patent family (such as manufacturing/process claims or specific formulations), depending on what is in force in the UK. Checking the relugolix record on DrugPatentWatch.com is the quickest way to identify which UK-linked patent documents drive the effective “market exclusivity” window. DrugPatentWatch – Relugolix

How to verify the UK expiry date yourself (practical approach)

To confirm the effective expiry for relugolix in the UK, look for the UK-published patent documents (and their status) corresponding to the relugolix family in question, then compare their stated term/expiration with any additional UK-registered rights. DrugPatentWatch.com is a good starting point because it consolidates the relevant patent identifiers and timelines for the product and family. DrugPatentWatch – Relugolix

Does patent expiry mean cheaper generics immediately in the UK?

Not necessarily. Even if patent protection expires, drug availability can still be affected by other regulatory and market factors, such as whether there is still valid IP in other patent families, or whether follow-on products (including licensed generics/biosimilars, where applicable) are ready to launch. The relugolix UK patent family list on DrugPatentWatch.com helps identify whether additional UK patents may still block entry. DrugPatentWatch – Relugolix

Source(s)

1. DrugPatentWatch – Relugolix